Next-Generation Sequencing – News and Features

News
Within the Next 10 Years it is Anticipated that Metabolomics will Become a Standard Tool in the Pharma Industry
Research and Markets announces the addition of "The Future of Metabolomics: Building Competitive Advantage in Drug Discovery, Clinical Development and Diagnostics"

News
Bio-Reference Laboratories Announces Agreement to Acquire GeneDx
Company signals major initiative into gene-based testing by acquiring GeneDx.

News
Next to Neanderthal: Human Great Ape Genome Helps Understand the Evolution of Man
Max Planck will use Roche’s Genome Sequencer 20 system to produce a draft genome sequence for the Bonobo or Pygmy Chimpanzee.

News
Applied Biosystems Creates Software Development Community to Encourage Innovation In Life Science Technologies
Program provides scientists and software developers access to tools for building life science research applications.

News
NIH Seeks Input on Proposed Repository for Genetic Information
NIH has published a Request for Information in the Federal Register and will be accepting public comments until October 31.

News
Mitochondrial DNA Sequencing Tool Updated
NIH grantees report they have developed a second generation "lab on a silicon chip" called the MitoChip v2.0 that sequences all mitochondrial DNA.

News
NIH Funds Fourteen High-End Instrumentation Grants
Awarded to research institutions around the country, the one-time grants support the purchase of sophisticated instruments costing more than $750,000.

News
Genome Sequencer 20 Used for Genome-wide Discovery of Small RNAs
Researcher used the Genome Sequencer 20 to sequence RNAs from a dcl2 dcl3 dcl4 triple mutant.

News
Technical University Munich Licences Genomatix Microarray Analysis Pipeline
The agreement gives Center for Nurtigenomics full access to the Genomatix Microarray Analysis Pipeline.

News
Analyze Americans' Attitudes toward Pharmacogenomics and Personalized Medicine
In this report, Research and Markets examine how the use of pharmacogenomics will affect today's drug development strategies.
Advertisement